Xintela AB (OSTO:XINT) FCF Margin %: -2,919.19% (As of Mar. 2026)


OSTO:XINT Xintela AB OSTO:XINT
12 GF Score
Price kr0.18
! 2 Warning Signs
View Full Analysis

What is Xintela AB FCF Margin %?

Xintela AB OSTO:XINT -6.25% 12 FCF Margin % is -2,919.19% as of Mar. 2026. GuruFocus rates OSTO:XINT with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Xintela AB ranks worse than 83.52% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Xintela AB's Free Cash Flow for the three months ended in Mar. 2026 was kr-12.93 Mil. Xintela AB's Revenue for the three months ended in Mar. 2026 was kr0.44 Mil. Therefore, Xintela AB's FCF Margin % for the quarter that ended in Mar. 2026 was -2,919.19%.

As of today, Xintela AB's current FCF Yield % is -28.64%.

The historical rank and industry rank for Xintela AB's FCF Margin % or its related term are showing as below:

OSTO:XINT' s FCF Margin % Range Over the Past 10 Years
Min: -822250   Med: -68230.77   Max: -965.69
Current: -1717.87

During the past 13 years, the highest FCF Margin % of Xintela AB was -965.69%. The lowest was -822250.00%. And the median was -68230.77%.

OSTO:XINT's FCF Margin % is ranked worse than
83.52% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs OSTO:XINT: -1717.87

Xintela AB FCF Margin % Related Terms

Xintela AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Xintela AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xintela AB FCF Margin % Chart

Xintela AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -68,230.77 -965.69 -1,823.75

Xintela AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,295.71 -702.41 -787.84 -4,485.30 -2,919.19

OSTO:XINT vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Xintela AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xintela AB FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xintela AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Xintela AB's FCF Margin % falls into.


OSTO:XINT
12GF Score
Xintela AB OSTO:XINT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xintela AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Xintela AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-41.618/2.282
=-1,823.75 %

Xintela AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-12.932/0.443
=-2,919.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -2,919.19% mean?
Xintela AB (OSTO:XINT) has a FCF Margin % of -2,919.19% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Xintela AB and its competitors. According to the industry distribution chart, Xintela AB ranks #801 out of 959 companies in the Biotechnology industry, placing it in the top 83.5%.
Is Xintela AB's FCF Margin % too high?
Xintela AB's current FCF Margin % is -2,919.19%. Based on the distribution chart, Xintela AB ranks #801 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Xintela AB has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Xintela AB's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xintela AB ranks #801 out of 959 companies for FCF Margin %. This places Xintela AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Xintela AB and its competitors. Xintela AB's current FCF Margin % is -2,919.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xintela AB stock overvalued right now?
Xintela AB (OSTO:XINT) has a current FCF Margin % of -2,919.19%. The current FCF Margin % is -2,919.19%. Xintela AB's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Xintela AB (OSTO:XINT), the current FCF Margin % is -2,919.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xintela AB Business Description

Other Exchanges 1XT:Germany
Address Medicon Village, Lund, SWE, 223 81
Xintela AB is a clinical-stage biopharmaceutical company that develops cutting-edge medical products in stem cell therapy and targeted cancer therapy. Its wholly owned subsidiary, Targinta AB, develops First-in-Class therapeutic antibodies targeting integrin ?10?1. TARG9, an antibody-drug conjugate (ADC), and TARG10, a function-blocking antibody, are in preclinical development for the treatment of aggressive, difficult-to-treat cancers, including triple-negative breast cancer and brain tumor glioblastoma. Xintela has two clinical studies ongoing with the stem cell product XSTEM and EQSTEM.
12GF Score

Get the complete analysis for OSTO:XINT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.18
Price